TY - JOUR A1 - Fischer, Franziska A1 - Schmidt, M. U. A1 - Greiser, Sebastian A1 - Emmerling, Franziska T1 - The challenging case of the theophylline–benzamide cocrystal N2 - Theophylline has been used as an active pharmaceutical ingredient (API) in the treatment of pulmonary diseases, but due to its low water solubility reveals very poor bioavailability. Based on its different hydrogen-bond donor and acceptor groups, theophylline is an ideal candidate for the formation of cocrystals. The crystal structure of the 1:1 benzamide cocrystal of theophylline, C7H8N4O2·-C7H7NO, was determined from synchrotron X-ray powder diffraction data. The compound crystallizes in the tetragonal space group P41 with four Independent molecules in the asymmetric unit. The molecules form a hunter’s fence packing. The crystal structure was confirmed by dispersion-corrected DFT calculations. The possibility of salt formation was excluded by the results of Raman and 1H solid-state NMR spectroscopic analyses. KW - powder diffraction KW - theophylline KW - benzamide KW - cocrystal KW - crystal structure KW - active pharmaceutical ingredient KW - dispersion-corrected density-functional theory PY - 2016 U6 - https://doi.org/10.1107/S2053229616002643 SN - 2053-2296 VL - 72 IS - 3 SP - 217 EP - 224 AN - OPUS4-35621 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER -